Lymphoma Treatment 2016: Current and Future Approaches to Care
Sven de Vos, MD, PhD
About the Lecture
Lymphoma represents a collection of blood cancers that arise from the lymphoid cells of the immune system. An estimated 80,000 people will be diagnosed with lymphoma in 2016, the majority of these will be non-Hodgkin lymphomas and approximately. There are over 60 different types of non-Hodgkin lymphoma. The field of lymphoma research is rapidly evolving as we learn more about the underlying biology and novel treatment options of each type of lymphoma. Several new, exciting therapies, are either recently FDA approved or currently in clinical trials. The different types of lymphoma, the general approach to treatment, and the new targeted therapies that have recently been reported or are currently in clinical trials are discussed.
About the Speaker
Sven de Vos, MD, PhD is an Associate Professor of Medicine in the Div. of Hematology/Oncology at the David Geffen School of Medicine at UCLA, where he is a member of the Jonsson Comprehensive Cancer Center and the Stem Cell Biology Program Area. His clinical interests are lymphoma and stem cell transplantation; his research interests include translational oncology and experimental pathology. As Director of the UCLA lymphoma program his research interest focuses on the development of novel therapeutics and he serves as principal investigator on many local, national, and international clinical trial protocols for non-Hodgkin lymphoma, Hodgkin lymphoma, and CLL.